EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel COE-D8-fosfomycin conjugate effectively combats first-line antibiotic-resistant uropathogenic Escherichia coli

Lin Ruan iD, Cun Fan, Jingjie Chen, Yingxia Wang, Yuji Ren, Wenli Yuan, Xiaozhe Xiong, Chunming Guo iD

PLOS One · 08.07.2026 · 21 (7) · e0352997

DOI: 10.1371/journal.pone.0352997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 08.07.2026. Verfasst von Lin Ruan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Yunnan University(YNU), Kunming, China. Hauptthemen laut MEDLINE: Uropathogenic Escherichia coli, Fosfomycin, Anti-Bacterial Agents, Escherichia coli Infections. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Yunnan Province of China, Xingdian talent support program of Yunnan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recurrent urinary tract infections (UTIs) caused by multidrug-resistant uropathogenic Escherichia coli (UPEC) demand novel antimicrobial approaches. This study evaluated the membrane-intercalating conjugated oligoelectrolyte COE-D8 against 93 clinical UPEC isolates. While >75% of isolates exhibited high-level resistance to first-line antibiotics (MIC > 512 μg/mL), 94.6% remained susceptible to COE-D8 at ≤32 μg/mL. COE-D8 eliminated bacteria fourfold faster than standard antibiotics through membrane disruption driven by a dimensional mismatch with the lipid bilayer. To mitigate the inherent cytotoxicity of COE-D8 alone, we developed a synergistic co-administration strategy with fosfomycin. This approach achieved a significant dose-sparing effect, rescuing 7-day murine survival from 40% to 80% in safety models without compromising efficacy. Furthermore, resistance induction studies identified a high barrier to adaptation, with survival primarily mediated by mzrA mutations. These findings establish the COE-D8/fosfomycin combination as a host-friendly, mechanism-driven strategy against refractory UPEC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uropathogenic Escherichia coliFosfomycinAnti-Bacterial AgentsEscherichia coli InfectionsUrinary Tract InfectionsAnimalsMicrobial Sensitivity TestsMiceHumansDrug Resistance, Multiple, Bacterial

Substanzen

FosfomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • School of Life Sciences, Yunnan University(YNU), Kunming, China.
  • Yunnan Key Laboratory of Cell Metabolism and Disease, Yunnan, China.
  • Guangzhou Laboratory, Guangzhou, China.
  • The Department of Pathology, First affiliated Hospital of Kunming Medical University, Kunming, China.
  • The Department of Clinical Laboratory, First affiliated Hospital of Kunming Medical University, Kunming, China.
  • Department of Clinical Laboratory, The Affiliated Hospital of Yunnan University (The Second People's Hospital of Yunnan Province), Kunming, China.

ORCID-Profile: Lin Ruan, Chunming Guo

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Yunnan Province of China
  • Xingdian talent support program of Yunnan Province
  • Guangdong Hybribio Biotech Funding

Zitieren

APA

Ruan, L., Fan, C., Chen, J., Wang, Y., Ren, Y., Yuan, W., Xiong, X., & Guo, C. (2026). A novel COE-D8-fosfomycin conjugate effectively combats first-line antibiotic-resistant uropathogenic Escherichia coli. PLOS One, 21(7), e0352997. https://doi.org/10.1371/journal.pone.0352997

Vancouver

Ruan L, Fan C, Chen J, Wang Y, Ren Y, Yuan W, et al. A novel COE-D8-fosfomycin conjugate effectively combats first-line antibiotic-resistant uropathogenic Escherichia coli. PLOS One. 2026;21(7):e0352997. doi:10.1371/journal.pone.0352997

BibTeX
@article{Ruan2026,
  author = {Ruan, Lin and Fan, Cun and Chen, Jingjie and Wang, Yingxia and Ren, Yuji and Yuan, Wenli and Xiong, Xiaozhe and Guo, Chunming},
  title = {A novel COE-D8-fosfomycin conjugate effectively combats first-line antibiotic-resistant uropathogenic Escherichia coli},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {7},
  pages = {e0352997},
  doi = {10.1371/journal.pone.0352997}
}
Kostenlos starten →